Beijing Hotgen Biotech Co., Ltd.

SHSE:688068 Stock Report

Market Cap: CN¥5.2b

Beijing Hotgen Biotech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Changqing Lin

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership24.2%
Management average tenureno data
Board average tenure2.4yrs

Recent management updates

Recent updates

There's Reason For Concern Over Beijing Hotgen Biotech Co., Ltd.'s (SHSE:688068) Massive 28% Price Jump

Mar 06
There's Reason For Concern Over Beijing Hotgen Biotech Co., Ltd.'s (SHSE:688068) Massive 28% Price Jump

CEO

Changqing Lin (48 yo)

no data

Tenure

CN¥1,760,800

Compensation

Mr. Changqing Lin serves as Chairman of the Board and General Manager at Beijing Hotgen Biotech Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Changqing Lin
Chairman & GMno dataCN¥1.76m24.2%
CN¥ 1.3b
Xiaoli Liu
Director2.4yrsCN¥571.40k0.015%
CN¥ 780.1k
Changyuan Yu
Independent Director2.4yrsCN¥120.00kno data
Jianguo Chen
Supervisor1.3yrsno datano data

2.4yrs

Average Tenure

46yo

Average Age

Experienced Board: 688068's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 06:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Hotgen Biotech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Xinming ZhouTopsperity Securities